(NASDAQ: COYA) Coya Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 43.76%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.65%.
Coya Therapeutics's earnings in 2025 is -$18,433,341.On average, 9 Wall Street analysts forecast COYA's earnings for 2025 to be -$25,098,885, with the lowest COYA earnings forecast at -$27,888,115, and the highest COYA earnings forecast at -$21,750,972. On average, 9 Wall Street analysts forecast COYA's earnings for 2026 to be -$31,658,702, with the lowest COYA earnings forecast at -$36,090,502, and the highest COYA earnings forecast at -$28,342,176.
In 2027, COYA is forecast to generate -$26,607,538 in earnings, with the lowest earnings forecast at -$42,652,411 and the highest earnings forecast at -$12,303,580.